• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新辅助化疗后 1-3 枚前哨淋巴结阳性的乳腺癌患者术中非前哨淋巴结转移预测。

Non-sentinel node metastasis prediction during surgery in breast cancer patients with one to three positive sentinel node(s) following neoadjuvant chemotherapy.

机构信息

Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-Gu, Seoul, 05505, Republic of Korea.

出版信息

Sci Rep. 2023 Mar 18;13(1):4480. doi: 10.1038/s41598-023-31628-2.

DOI:10.1038/s41598-023-31628-2
PMID:36934173
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10024769/
Abstract

Our aim was to develop a tool to accurately predict the possibility of non-sentinel lymph node metastasis (NSLNM) during surgery so that a surgeon might decide the extent of further axillary lymph node dissection intraoperatively for patients with 1-3 positive sentinel lymph node(s) (SLN) after neoadjuvant chemotherapy. After retrospective analysis of Asan Medical Center (AMC) database, we included 558 patients' records who were treated between 2005 and 2019. 13 factors were assessed for their utility to predict NSLNM with chi-square and logistic regression with a bootstrapped, backward elimination method. Based on the result of the univariate analysis for statistical significance, number of positive SLN(s), number of frozen nodes, Progesterone Receptor (PR) positivity, clinical N stage were selected for the multivariate analysis and were utilized to generate a nomogram for prediction of residual nodal disease. The resulting nomogram was tested for validation by using a patient group of more recent, different time window at AMC. We designed a nomogram to be predictive of the NSLNM which consisted of 4 components: number of SLN(s), number of frozen nodes, PR positivity, and clinical N stage before neoadjuvant chemotherapy. The Area under the receiver operating characteristics curve (AUC) value of this formula was 0.709 (95% CI, 0.658-0.761) for development set and 0.715 (95% CI, 0.634-0.796) for validation set, respectively. This newly created AMC nomogram may provide a useful information to a surgeon for intraoperative guidance to decide the extent of further axillary surgery.

摘要

我们的目的是开发一种工具,以便在手术中准确预测非前哨淋巴结转移(NSLNM)的可能性,从而使外科医生能够在新辅助化疗后 1-3 个前哨淋巴结(SLN)阳性的患者中,在手术中决定进一步腋窝淋巴结清扫的程度。对 Asan 医疗中心(AMC)数据库进行回顾性分析后,我们纳入了 558 名患者的记录,这些患者在 2005 年至 2019 年期间接受了治疗。采用卡方检验和逻辑回归(带 bootstrap,逐步向后消除法)评估了 13 个因素对预测 NSLNM 的作用。基于单变量分析的统计学意义、SLN 阳性数量、冷冻节点数量、孕激素受体(PR)阳性、临床 N 分期等因素,进行多变量分析,并生成预测残留淋巴结疾病的列线图。使用 AMC 近期不同时间窗口的患者组对生成的列线图进行验证。我们设计了一个列线图来预测 NSLNM,该列线图由 4 个部分组成:SLN 数量、冷冻节点数量、PR 阳性和新辅助化疗前的临床 N 分期。该公式的受试者工作特征曲线(ROC)下面积(AUC)值在开发组中为 0.709(95%CI,0.658-0.761),在验证组中为 0.715(95%CI,0.634-0.796)。这个新创建的 AMC 列线图可能为外科医生提供有用的信息,以指导术中决定进一步腋窝手术的范围。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e2c/10024769/dba16f2b719c/41598_2023_31628_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e2c/10024769/e650f7fbc104/41598_2023_31628_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e2c/10024769/dba16f2b719c/41598_2023_31628_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e2c/10024769/e650f7fbc104/41598_2023_31628_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e2c/10024769/dba16f2b719c/41598_2023_31628_Fig2_HTML.jpg

相似文献

1
Non-sentinel node metastasis prediction during surgery in breast cancer patients with one to three positive sentinel node(s) following neoadjuvant chemotherapy.新辅助化疗后 1-3 枚前哨淋巴结阳性的乳腺癌患者术中非前哨淋巴结转移预测。
Sci Rep. 2023 Mar 18;13(1):4480. doi: 10.1038/s41598-023-31628-2.
2
Prediction of non-sentinel lymph node metastases in T1-2 sentinel lymph node-positive breast cancer patients undergoing mastectomy following neoadjuvant therapy.新辅助治疗后行乳房切除术的 T1-2 前哨淋巴结阳性乳腺癌患者中非前哨淋巴结转移的预测。
World J Surg Oncol. 2024 Sep 28;22(1):258. doi: 10.1186/s12957-024-03537-9.
3
Predictive Factors for Nonsentinel Lymph Node Metastasis in Patients With Positive Sentinel Lymph Nodes After Neoadjuvant Chemotherapy: Nomogram for Predicting Nonsentinel Lymph Node Metastasis.新辅助化疗后前哨淋巴结阳性患者非前哨淋巴结转移的预测因素:预测非前哨淋巴结转移的列线图。
Clin Breast Cancer. 2017 Nov;17(7):550-558. doi: 10.1016/j.clbc.2017.03.014. Epub 2017 Apr 6.
4
Development and external validation of a nomogram to predict four or more positive nodes in breast cancer patients with one to three positive sentinel lymph nodes.建立并外部验证一个列线图模型,以预测 1-3 枚前哨淋巴结阳性的乳腺癌患者中存在 4 枚及以上阳性淋巴结的情况。
Breast. 2020 Oct;53:143-151. doi: 10.1016/j.breast.2020.08.001. Epub 2020 Aug 10.
5
A nomogram to predict non-sentinel lymph node metastasis in patients with initial cN+ breast cancer that downstages to cN0 after neoadjuvant chemotherapy.用于预测初始 cN+乳腺癌患者在新辅助化疗后降期为 cN0 后发生非前哨淋巴结转移的列线图。
J Surg Oncol. 2020 Sep;122(3):373-381. doi: 10.1002/jso.25989. Epub 2020 May 20.
6
Can a machine-learning model improve the prediction of nodal stage after a positive sentinel lymph node biopsy in breast cancer?机器学习模型能否提高乳腺癌前哨淋巴结活检阳性后的淋巴结分期预测?
Acta Oncol. 2020 Jun;59(6):689-695. doi: 10.1080/0284186X.2020.1736332. Epub 2020 Mar 9.
7
Validation of breast cancer nomograms for predicting the non-sentinel lymph node metastases after a positive sentinel lymph node biopsy in a multi-center study.多中心研究中验证用于预测前哨淋巴结活检阳性后非前哨淋巴结转移的乳腺癌列线图。
Eur J Surg Oncol. 2010 Jan;36(1):30-5. doi: 10.1016/j.ejso.2009.05.007. Epub 2009 Jun 16.
8
[A nomogram to predict non-sentinel lymph node metastasis for breast cancer patients with positive axillary sentinel lymph node].[预测腋窝前哨淋巴结阳性乳腺癌患者非前哨淋巴结转移的列线图]
Zhonghua Zhong Liu Za Zhi. 2020 Aug 23;42(8):653-659. doi: 10.3760/cma.j.cn112152-20190824-00545.
9
Factors Influencing Non-sentinel Lymph Node Involvement in Patients with Positive Sentinel Lymph Node(s) After Neoadjuvant Chemotherapy for Breast Cancer.新辅助化疗后前哨淋巴结阳性乳腺癌患者非前哨淋巴结受累的影响因素。
Ann Surg Oncol. 2022 Nov;29(12):7769-7778. doi: 10.1245/s10434-022-12064-4. Epub 2022 Jul 13.
10
Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy.新辅助化疗后前哨淋巴结阳性患者腋窝出现额外疾病的预测因素。
Cancer. 2008 Jun 15;112(12):2646-54. doi: 10.1002/cncr.23481.

引用本文的文献

1
Evaluating the survival outcomes in clinical node stage 2 and 3 breast cancer patients with negative sentinel lymph node biopsy after neoadjuvant chemotherapy: sentinel lymph node biopsy alone vs. axillary lymph node dissection.评估新辅助化疗后前哨淋巴结活检阴性的临床淋巴结分期为2期和3期乳腺癌患者的生存结局:单纯前哨淋巴结活检与腋窝淋巴结清扫术的比较
Front Oncol. 2025 May 20;15:1563586. doi: 10.3389/fonc.2025.1563586. eCollection 2025.

本文引用的文献

1
Comparison of survival outcomes for axillary surgery extent based on intraoperative sentinel lymph node biopsy result after neoadjuvant chemotherapy for breast cancer.基于新辅助化疗后乳腺癌术中前哨淋巴结活检结果的腋窝手术范围对生存结局的比较。
Breast Cancer Res Treat. 2021 Jun;187(3):647-655. doi: 10.1007/s10549-021-06249-w. Epub 2021 May 8.
2
Development and validation of nomograms for predicting axillary non-SLN metastases in breast cancer patients with 1-2 positive sentinel lymph node macro-metastases: a retrospective analysis of two independent cohorts.建立并验证用于预测 1-2 枚前哨淋巴结宏转移的乳腺癌患者腋窝非前哨淋巴结转移的列线图:两项独立队列的回顾性分析。
BMC Cancer. 2021 Apr 26;21(1):466. doi: 10.1186/s12885-021-08178-9.
3
Omission of Axillary Lymph Node Dissection is Associated with Inferior Survival in Breast Cancer Patients with Residual N1 Nodal Disease Following Neoadjuvant Chemotherapy.对于新辅助化疗后仍有N1淋巴结残留疾病的乳腺癌患者,省略腋窝淋巴结清扫与较差的生存率相关。
Ann Surg Oncol. 2021 Feb;28(2):930-940. doi: 10.1245/s10434-020-08928-2. Epub 2020 Jul 25.
4
ASO Author Reflections: Rate of Axillary Lymph Node Dissection has Decreased in Patients Treated with Neoadjuvant Systemic Therapy.ASO作者反思:接受新辅助全身治疗的患者腋窝淋巴结清扫率有所下降。
Ann Surg Oncol. 2018 Dec;25(Suppl 3):693-694. doi: 10.1245/s10434-018-7045-x. Epub 2018 Nov 12.
5
Decreasing Use of Axillary Dissection in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.新辅助化疗治疗腋窝淋巴结阳性乳腺癌患者中腋窝清扫术的应用减少。
Ann Surg Oncol. 2018 Sep;25(9):2596-2602. doi: 10.1245/s10434-018-6637-9. Epub 2018 Jul 5.
6
Predictive Factors for Nonsentinel Lymph Node Metastasis in Patients With Positive Sentinel Lymph Nodes After Neoadjuvant Chemotherapy: Nomogram for Predicting Nonsentinel Lymph Node Metastasis.新辅助化疗后前哨淋巴结阳性患者非前哨淋巴结转移的预测因素:预测非前哨淋巴结转移的列线图。
Clin Breast Cancer. 2017 Nov;17(7):550-558. doi: 10.1016/j.clbc.2017.03.014. Epub 2017 Apr 6.
7
Axillary Nodal Management Following Neoadjuvant Chemotherapy: A Review.腋窝淋巴结管理:新辅助化疗后的回顾。
JAMA Oncol. 2017 Apr 1;3(4):549-555. doi: 10.1001/jamaoncol.2016.4163.
8
Is sentinel lymph node biopsy a viable alternative to complete axillary dissection following neoadjuvant chemotherapy in women with node-positive breast cancer at diagnosis? An updated meta-analysis involving 3,398 patients.对于诊断时淋巴结阳性的乳腺癌女性患者,前哨淋巴结活检能否作为新辅助化疗后全腋窝清扫术的可行替代方案?一项纳入3398例患者的最新荟萃分析。
Am J Surg. 2016 Nov;212(5):969-981. doi: 10.1016/j.amjsurg.2016.07.018. Epub 2016 Aug 16.
9
Validation of Six Nomograms for Predicting Non-sentinel Lymph Node Metastases in a Dutch Breast Cancer Population.六种预测荷兰乳腺癌人群非前哨淋巴结转移列线图的验证
Ann Surg Oncol. 2016 Feb;23(2):477-81. doi: 10.1245/s10434-015-4858-8. Epub 2015 Sep 14.
10
Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy.接受新辅助化疗的乳腺癌患者的手术问题。
Nat Rev Clin Oncol. 2015 Jun;12(6):335-43. doi: 10.1038/nrclinonc.2015.63. Epub 2015 Apr 7.